• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The pitfalls of evaluating asthma control in children and adolescents.

作者信息

Carvalho-Pinto Regina Maria de, Lumertz Magali Santos, Chong-Silva Débora Carla

机构信息

. Divisão de Pneumologia, Instituto do Coração - InCor - Hospital das Clínicas, Faculdade de Medicina, Universidade de São Paulo, São Paulo (SP) Brasil.

. Escola de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul, Porto Alegre (RS) Brasil.

出版信息

J Bras Pneumol. 2025 Jun 13;51(2):e20250145. doi: 10.36416/1806-3756/e20250145.

DOI:10.36416/1806-3756/e20250145
PMID:40531744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12401109/
Abstract
摘要

相似文献

1
The pitfalls of evaluating asthma control in children and adolescents.评估儿童和青少年哮喘控制情况的陷阱。
J Bras Pneumol. 2025 Jun 13;51(2):e20250145. doi: 10.36416/1806-3756/e20250145.
2
Association between asthma and oral conditions in children and adolescents: a systematic review with meta-analysis.儿童和青少年哮喘与口腔疾病之间的关联：一项系统评价与荟萃分析
Clin Oral Investig. 2023 Jan;27(1):45-67. doi: 10.1007/s00784-022-04803-4. Epub 2022 Dec 2.
3
Inhaled corticosteroids and asthma control in children: assessing impairment and risk.吸入性糖皮质激素与儿童哮喘控制：评估损害与风险
Pediatrics. 2009 Jan;123(1):353-66. doi: 10.1542/peds.2007-3273.
4
Regular versus as-needed treatments for mild asthma in children, adolescents, and adults: a systematic review and network meta-analysis.儿童、青少年和成人轻度哮喘的常规治疗与按需治疗：一项系统评价和网状Meta分析
BMC Med. 2025 Jan 21;23(1):21. doi: 10.1186/s12916-025-03847-z.
5
Levels of physical activity in children and adolescents with asthma: A systematic review and meta-analysis.儿童和青少年哮喘患者的身体活动水平：系统评价和荟萃分析。
Pediatr Pulmonol. 2021 Jun;56(6):1307-1323. doi: 10.1002/ppul.25293. Epub 2021 Feb 9.
6
Pharmacogenetic studies of long-acting beta agonist and inhaled corticosteroid responsiveness in randomised controlled trials of individuals of African descent with asthma.在针对非洲裔哮喘患者的随机对照试验中，对长效β激动剂和吸入皮质类固醇反应性的药物遗传学研究。
Lancet Child Adolesc Health. 2021 Dec;5(12):862-872. doi: 10.1016/S2352-4642(21)00268-6. Epub 2021 Nov 9.
7
Swimming training for asthma in children and adolescents aged 18 years and under.18岁及以下儿童和青少年哮喘患者的游泳训练
Cochrane Database Syst Rev. 2013 Apr 30(4):CD009607. doi: 10.1002/14651858.CD009607.pub2.
8
Omalizumab for the treatment of severe persistent allergic asthma: a systematic review and economic evaluation.奥马珠单抗治疗严重持续性过敏性哮喘：系统评价和经济评估。
Health Technol Assess. 2013 Nov;17(52):1-342. doi: 10.3310/hta17520.
9
Acute asthma in children and adolescents: should inhaled anticholinergics be added to beta(2)-agonists?儿童和青少年的急性哮喘：是否应在β2受体激动剂中添加吸入性抗胆碱能药物？
Am J Respir Med. 2003;2(2):109-15. doi: 10.1007/BF03256642.
10
Risk factors for asthma across India: Results from global asthma network (GAN) phase I study.印度各地哮喘的风险因素：全球哮喘网络（GAN）第一阶段研究结果
Lung India. 2025 Jul 1;42(4):291-298. doi: 10.4103/lungindia.lungindia_626_24. Epub 2025 Jun 27.

本文引用的文献

1
Level of agreement between two asthma control questionnaires in children and adolescents.两种儿童及青少年哮喘控制问卷之间的一致性水平。
J Bras Pneumol. 2025 Jun 13;51(2):e20240407. doi: 10.36416/1806-3756/e20240407. eCollection 2025.
2
Global, regional, national burden of asthma from 1990 to 2021, with projections of incidence to 2050: a systematic analysis of the global burden of disease study 2021.1990年至2021年全球、区域和国家哮喘负担及到2050年的发病率预测：全球疾病负担研究2021的系统分析
EClinicalMedicine. 2025 Jan 9;80:103051. doi: 10.1016/j.eclinm.2024.103051. eCollection 2025 Feb.
3
Early family socioeconomic status and asthma-related outcomes in school-aged children: Results from seven birth cohort studies.学龄儿童早期家庭社会经济地位与哮喘相关结局：七项出生队列研究的结果
J Epidemiol Community Health. 2024 Dec 10;79(1):1-11. doi: 10.1136/jech-2023-220726.
4
Asthma in the Brazilian Unified Health Care System: an epidemiological analysis from 2008 to 2021.巴西统一医疗保健系统中的哮喘：2008 年至 2021 年的流行病学分析。
J Bras Pneumol. 2024 May 27;50(2):e20230364. doi: 10.36416/1806-3756/e20230364. eCollection 2024.
5
Asthma management and control in children, adolescents, and adults in 25 countries: a Global Asthma Network Phase I cross-sectional study.25 个国家儿童、青少年和成人的哮喘管理和控制：全球哮喘网络第一阶段横断面研究。
Lancet Glob Health. 2023 Feb;11(2):e218-e228. doi: 10.1016/S2214-109X(22)00506-X.
6
The Global Asthma Report 2022.《2022年全球哮喘报告》
Int J Tuberc Lung Dis. 2022 Nov 25;26(Supp 1):1-104. doi: 10.5588/ijtld.22.1010.
7
Asthma in the Americas: An Update: A Joint Perspective from the Brazilian Thoracic Society, Canadian Thoracic Society, Latin American Thoracic Society, and American Thoracic Society.美洲的哮喘：最新进展：巴西胸科学会、加拿大胸科学会、拉丁美洲胸科学会和美国胸科学会的联合视角。
Ann Am Thorac Soc. 2022 Apr;19(4):525-535. doi: 10.1513/AnnalsATS.202109-1068CME.
8
The real-world "ControL'Asma" study: a nationwide taskforce on asthma control in children and adolescents.真实世界“ControL'Asma”研究：全国范围内针对儿童和青少年哮喘控制的专项工作组。
Allergol Immunopathol (Madr). 2021 Jan 2;49(1):32-39. doi: 10.15586/aei.v49i1.14. eCollection 2021.
9
Provision of inhaled corticosteroids is associated with decrease in hospital admissions in Brazil: A longitudinal nationwide study.吸入皮质类固醇的提供与巴西住院人数减少有关：一项全国性纵向研究。
Respir Med. 2020 May;166:105950. doi: 10.1016/j.rmed.2020.105950. Epub 2020 Mar 30.
10
Cost-benefit impact of free asthma medication provision for the pediatric population.免费提供哮喘药物对儿科人群的成本效益影响。
Respir Med. 2020 Apr;164:105915. doi: 10.1016/j.rmed.2020.105915. Epub 2020 Feb 25.